| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 6.84 mm | 6.84 mm | 6.84 mm | 6.84 mm | 6.84 mm | 6.84 mm |
| Cash burn (monthly) | 328.05 k | 323.85 k | 166.49 k | 347.52 k | (no burn) | 239.54 k |
| Cash used (since last report) | 923.73 k | 911.90 k | 468.81 k | 978.56 k | n/a | 674.50 k |
| Cash remaining | 5.92 mm | 5.93 mm | 6.37 mm | 5.86 mm | n/a | 6.17 mm |
| Runway (months of cash) | 18.0 | 18.3 | 38.3 | 16.9 | n/a | 25.7 |
| 13F holders | Current |
|---|---|
| Total holders | 9 |
| Opened positions | 1 |
| Closed positions | 12 |
| Increased positions | 0 |
| Reduced positions | 8 |
| 13F shares | Current |
|---|---|
| Total value | 26.90 mm |
| Total shares | 184.13 k |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| CLS Therapeutics | 147.50 k | $471.00 k |
| Renaissance Technologies | 25.78 k | $85.00 k |
| RY Royal Bank of Canada | 5.30 k | $17.00 mm |
| JTC Employer Solutions Trusteee | 2.70 k | $9.00 k |
| Steward Partners Investment Advisory | 1.90 k | $6.23 mm |
| Tower Research Capital | 621.00 | $2.04 mm |
| MS Morgan Stanley | 295.00 | $967.00 k |
| NewSquare Capital | 26.00 | $85.00 k |
| FMR | 7.00 | $22.00 k |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Dec 24 | Kornberg Roger D. | Stock Options Common Stock | Grant | Acquire A | No | No | 4.24 | 2,500 | 10.60 k | 2,500 |
| 11 Dec 24 | Borisenko Grigory G. | Stock Options Common Stock | Grant | Acquire A | No | No | 4.24 | 2,500 | 10.60 k | 2,500 |
| 11 Dec 24 | Firdaus J. Dastoor | Stock Options Common Stock | Grant | Acquire A | No | No | 4.24 | 2,500 | 10.60 k | 2,500 |
| 11 Dec 24 | Alexey Andreevich Vinogradov | Stock Options Common Stock | Grant | Acquire A | No | No | 4.24 | 2,500 | 10.60 k | 2,500 |
| 18 Jun 24 | James F Parslow | Stock Options Common Stock | Grant | Acquire A | No | No | 3.99 | 20,000 | 79.80 k | 20,000 |
